J&J’s AIDS Vaccine Protects Half of Monkeys as Human Tests Start
This article is for subscribers only.
Johnson & Johnson’s experimental AIDS vaccine protected half the monkeys who received it in a study, boosting confidence in the possibility for a shot that would stop the world’s deadliest infectious disease in humans.
The vaccine protected six out of 12 animals who received it from becoming infected with the monkey version of HIV, according to findings published Thursday in the journal Science. J&J has started the first human trials of an AIDS vaccine since 2009 among 400 volunteers in the U.S., Thailand, South Africa, Rwanda and Uganda, and expects results next year.